LY285434 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as an inhibitor targeting specific enzymes that play a crucial role in the proliferation of cancer cells. Researchers employ this compound to understand the mechanisms of tumor growth and to evaluate its potential in developing targeted cancer treatments. Its application extends to preclinical studies where it helps in assessing the efficacy and safety of new therapeutic approaches, contributing significantly to advancements in oncology.